PepGen
PepGen is seeking an experienced Associate Director, Regulatory CMC to lead global regulatory activities for novel Enhanced Delivery Oligonucleotide therapeutics. The role involves developing regulatory strategies, providing scientific guidance throughout clinical development, and ensuring late-stage readiness. This hybrid position requires strong technical expertise and cross-functional collaboration in a dynamic biotechnology environment.
Headquarters
Boston, Massachusetts, United States
Company Size
51-200 employees
Founded
2018
PepGen is a clinical-stage biotechnology company developing peptide-enabled oligonucleotide therapeutics to treat serious genetic neuromuscular and neurological diseases. Their proprietary Enhanced Delivery Oligonucleotide (EDO) platform is designed to improve cellular uptake and tissue targeting of genetic therapies, with programs targeting conditions such as Duchenne muscular dystrophy and myotonic dystrophy. PepGen advances its pipeline through preclinical and clinical development, combining peptide chemistry and nucleic-acid expertise to address the root causes of debilitating genetic diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for PepGen.
(Senior) Director, Regulatory Affairs CMC
Transforming Hypertrophic Cardiomyopathy Care
Regulatory Affairs Lead
gloorlang
Senior CMC Regulatory Affairs (RA) Manager
AbCellera
Senior Director, CMC Regulatory Affairs
allogene
Associate Director / Senior Regulatory Affairs
gloorlang
Senior Manager, Regulatory Affairs CMC
shionogi